πŸ‡ΊπŸ‡Έ FDA
Patent

US 12428379

Acylsulfonamide KAT6A inhibitors

granted A61KA61K31/415A61K31/4155

Quick answer

US patent 12428379 (Acylsulfonamide KAT6A inhibitors) held by Olema Pharmaceuticals, Inc. expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Olema Pharmaceuticals, Inc.
Grant date
Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/415, A61K31/4155, A61K31/426, A61K31/436